Skip to main content

Dalrada Technology Group, Inc.

corporate_fare Company Profile

Dalrada Technology Group, Inc.

ITEC·OTC·Trade & Services·CIK 0000725394

Dalrada Financial Corporation accelerates positive change by developing transformative products and services across five business divisions: Genefic, Dalrada Climate Technology, Dalrada Precision Manufacturing, Dalrada Technologies, and Dalrada Corporate. The company's global solutions address climate change, healthcare industry gaps, and technology needs. The Genefic division provides advanced healthcare solutions, including products, services, and systems. This division focuses on developing key health products, medications, and comprehensive systems to improve quality of life and longevity globally. Genefic includes two main entities: Genefic Specialty Pharmacy, formerly Genefic Specialty Pharmacy Rx Solutions, is an Alabama-based pharmacy with over 30 years of experience in the retail medical and pharmaceutical industries. It specializes in expert care and disease state management through prescription management, education, nursing, and total health solutions. Genefic Pharmacy holds pharmacy licenses in all 50 States and Washington D.C. Genefic Infusion Rx is a Louisiana-based infusion pharmacy that manages all aspects of fluid and medication infusion via intravenous or subcutaneous application. It supports healthcare systems by enhancing the infusion process through efficient authorization and prescription management.

Dalrada Technology Group, Inc. (OTC:ITEC) is a publicly traded company in the Trade & Services sector. Wiseek monitors ITEC SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Dalrada Reports Worsening Financials, Going Concern, Material Weakness, and Details Highly Dilutive Financing
  • Dalrada Amends Financing Disclosure, Increasing Highly Dilutive Obligation to $25 Million
  • Dalrada Subsidiary Secures $25M Financing with Onerous Terms, Pledging Parent Assets and CEO Personal Guarantee
  • Dalrada CEO Details Strategic Refocus, Reports €720K Water Generator Order Amid Operational Progress Near 52-Week Low

Dilution Risk

Low risk

Filing-implied dilution signals for ITEC, detected from its recent SEC filings · based on capital-structure filings through 2026-02-21.

Going Concern Warning Issued · Worsening Financial Position

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with I →
$0.000001
52-week range · as of 2026-02-21 $0.000001 – $0.069
Market cap
$720.12
Volume
2K (0.1× avg)
3-mo avg 25.6K
Live data · 2026-07-29 05:27 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed ITEC - Latest Insights

ITEC
Feb 20, 2026, 9:31 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.000001
Real-time Price: $0.000001 info
Change: N/A info
Market Cap: $720.115 info
ITEC
Feb 02, 2026, 5:22 PM EST
Filing Type: 8-K/A
Importance Score:
9
Price at Filing: $0.000001
Real-time Price: $0.000001 info
Change: N/A info
Market Cap: $720.115 info
ITEC
Jan 27, 2026, 5:02 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.000001
Real-time Price: $0.000001 info
Change: N/A info
Market Cap: $720.115 info
ITEC
Jan 20, 2026, 10:48 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.000001
Real-time Price: $0.000001 info
Change: N/A info
Market Cap: $720.115 info